Skip to main content

Advertisement

SpringerLink
Log in

Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Far-ranging variation in the incidence of gallbladder cancer (GBC) and cholangiocarcinoma (CCA) in different geographic regions on the globe may reflect the risk factor distribution for these tumors

Methods

The authors give a comprehensive review on the known risk factors for GBC and CCA, and analyze both similarities and differences between the risk factors for the two main types of biliary cancer

Discussion and Conclusion

Leading risk factors for GBC include gallstones, female gender, and advancing age. Primary sclerosing cholangitis, nitrosamine exposure, choledochal cysts, Clonorchis sinensis and Opisthorchis viverrini represent important risk factors for CCA, although a specific risk factor cannot be identified for many patients. While both cancers affect mostly individuals in their sixth decade or older, CCA has a male predominance and GBC—a predilection for females. Although the current level of understanding of the molecular pathogenesis of GBC and CCA at the interface with specific risk factors is significantly lower than for other gastrointestinal malignancies, it continues to evolve and may soon open new avenues for the therapy of biliary cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 1995;75(1 Suppl):171–90.

    Article  PubMed  CAS  Google Scholar 

  2. Hamrick Jr RE, Liner FJ, Hastings PR, Cohn Jr I. Primary carcinoma of the gallbladder. Ann Surg. 1982;195(3):270–3.

    Article  PubMed  Google Scholar 

  3. Yamaguchi K, Chijiiwa K, Ichimiya H, Sada M, Kawakami K, Nishikata F, et al. Gallbladder carcinoma in the era of laparoscopic cholecystectomy. Arch Surg. 1996;131(9):981–4. discussion 985.

    Article  PubMed  CAS  Google Scholar 

  4. A prospective analysis of 1518 laparoscopic cholecystectomies. The Southern Surgeons Club. N Engl J Med. 1991;324(16):1073–8.

    Article  Google Scholar 

  5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.

    Article  PubMed  Google Scholar 

  6. Diehl AK. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst. 1980;65(6):1209–14.

    PubMed  CAS  Google Scholar 

  7. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis. 1994;14(2):109–14.

    Article  PubMed  CAS  Google Scholar 

  8. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. CA Cancer J Clin. 2006;56(2):106–30.

    Article  PubMed  Google Scholar 

  9. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33(6):1353–7.

    Article  PubMed  CAS  Google Scholar 

  10. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40(3):472–7.

    Article  PubMed  Google Scholar 

  11. West J, Wood H, Logan RF, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br J Cancer. 2006;94(11):1751–8.

    Article  PubMed  CAS  Google Scholar 

  12. Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra-and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98(12):873–5.

    Article  PubMed  Google Scholar 

  13. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37(6):806–13.

    Article  PubMed  Google Scholar 

  14. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10.

    Article  PubMed  Google Scholar 

  15. Jepsen P, Vilstrup H, Tarone RE, Friis S, Sorensen HT. Incidence rates of intra-and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst. 2007;99(11):895–7.

    Article  PubMed  Google Scholar 

  16. Rajagopalan V, Daines WP, Grossbard ML, Kozuch P. Gallbladder and biliary tract carcinoma: a comprehensive update, Part 1. Oncology. 2004;18(7):889–96.

    PubMed  Google Scholar 

  17. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case–control study. Gastroenterology. 2005;128(3):620–6.

    Article  PubMed  Google Scholar 

  18. Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oncol. 1999;10 Suppl 4:308–11.

    Article  PubMed  Google Scholar 

  19. Ben-Menachem T. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol. 2007;19(8):615–7.

    Article  PubMed  Google Scholar 

  20. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology. 2005;128(6):1655–67.

    Article  PubMed  Google Scholar 

  21. Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case–control study. Int J Cancer. 2007;120(3):638–41.

    Article  PubMed  CAS  Google Scholar 

  22. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, et al. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer. 2007;97(11):1577–82.

    Article  PubMed  CAS  Google Scholar 

  23. Ahrens W, Timmer A, Vyberg M, Fletcher T, Guenel P, Merler E, et al. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case–control study. Eur J Gastroenterol Hepatol. 2007;19(8):623–30.

    Article  PubMed  Google Scholar 

  24. Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy. Cancer Causes Control. 2001;12(10):959–64.

    Article  PubMed  CAS  Google Scholar 

  25. Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer. 1977;39(1):232–46.

    Article  PubMed  CAS  Google Scholar 

  26. Su CH, Shyr YM, Lui WY, P’Eng FK. Hepatolithiasis associated with cholangiocarcinoma. Br J Surg. 1997;84(7):969–73.

    Article  PubMed  CAS  Google Scholar 

  27. Chijiiwa K, Yamashita H, Yoshida J, Kuroki S, Tanaka M. Current management and long-term prognosis of hepatolithiasis. Arch Surg. 1995;130(2):194–7.

    Article  PubMed  CAS  Google Scholar 

  28. Chen MF. Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol. 1999;14(12):1144–9.

    Article  PubMed  CAS  Google Scholar 

  29. Lee CC, Wu CY, Chen GH. What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? J Gastroenterol Hepatol. 2002;17(9):1015–20.

    Article  PubMed  Google Scholar 

  30. Yamamoto K, Tsuchiya R, Ito I, et al. A study of cholangiocarcinoma coexisting with hepatolithiasis. Jpn J Gastroenterol Surg. 1984;17:601.

    Article  Google Scholar 

  31. Kinami Y, Noto H, Miyazaki I, et al. A study of hepatolithiasis associated with cholangiocarcinoma. Acta Hepatol Jpn. 1978;19:573.

    Article  Google Scholar 

  32. Paraskevopoulos JA, Dennison AR, Ross B, Johnson AG. Primary carcinoma of the gallbladder: a 10-year experience. Ann R Coll Surg Engl. 1992;74(3):222–4.

    PubMed  CAS  Google Scholar 

  33. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591–602.

    Article  PubMed  CAS  Google Scholar 

  34. Maringhini A, Moreau JA, Melton 3rd LJ, Hench VS, Zinsmeister AR, DiMagno EP. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med. 1987;107(1):30–5.

    PubMed  CAS  Google Scholar 

  35. Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, de Mesquita HB Bueno, Ghadirian P, et al. Epidemiologic aspects of gallbladder cancer: a case–control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst. 1997;89(15):1132–8.

    Article  PubMed  CAS  Google Scholar 

  36. Ghadirian P, Simard A, Baillargeon J. A population-based case–control study of cancer of the bile ducts and gallbladder in Quebec, Canada. Rev Épidémiol Santé Publique. 1993;41(2):107–12.

    PubMed  CAS  Google Scholar 

  37. Chow WH, Johansen C, Gridley G, Mellemkjaer L, Olsen JH, Fraumeni Jr JF. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer. 1999;79(3–4):640–4.

    Article  PubMed  CAS  Google Scholar 

  38. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4(3):167–76.

    Article  PubMed  Google Scholar 

  39. Glenn F, Hays DM. The scope of radical surgery in the treatment of malignant tumors of the extrahepatic biliary tract. Surg Gynecol Obstet. 1954;99(5):529–41.

    PubMed  CAS  Google Scholar 

  40. Sahani D, Prasad SR, Tannabe KK, Hahn PF, Mueller PR, Saini S. Thorotrast-induced cholangiocarcinoma: case report. Abdom Imaging. 2003;28(1):72–4.

    Article  CAS  PubMed  Google Scholar 

  41. Ishikawa Y, Wada I, Fukumoto M. Alpha-particle carcinogenesis in Thorotrast patients: epidemiology, dosimetry, pathology, and molecular analysis. J Environ Pathol Toxicol Oncol. 2001;20(4):311–5.

    PubMed  CAS  Google Scholar 

  42. Taylor GN, Lloyd RD, Mays CW, Angus W, Miller SC, Shabestari L, et al. Plutonium- or americium-induced liver tumors and lesions in beagles. Health Phys. 1991;61(3):337–47.

    Article  PubMed  CAS  Google Scholar 

  43. Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349–64.

    Article  PubMed  CAS  Google Scholar 

  44. Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev. 2003;12(4):269–72.

    Article  PubMed  CAS  Google Scholar 

  45. Darby SC, Whitley E, Howe GR, Hutchings SJ, Kusiak RA, Lubin JH, et al. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J Natl Cancer Inst. 1995;87(5):378–84.

    Article  PubMed  CAS  Google Scholar 

  46. Ellis EF, Gordon PR, Gottlieb LS. Oral contraceptives and cholangiocarcinoma. Lancet. 1978;1(8057):207.

    Article  PubMed  CAS  Google Scholar 

  47. Broden G, Bengtsson L. Biliary carcinoma associated with methyldopa therapy. Acta Chir Scand Suppl. 1980;500:7–12.

    PubMed  CAS  Google Scholar 

  48. Lowenfels AB, Norman J. Isoniazid and bile duct cancer. JAMA. 1978;240(5):434–5.

    Article  PubMed  CAS  Google Scholar 

  49. Milne R, Vessey M. The association of oral contraception with kidney cancer, colon cancer, gallbladder cancer (including extrahepatic bile duct cancer) and pituitary tumours. Contraception. 1991;43(6):667–93.

    Article  PubMed  CAS  Google Scholar 

  50. The WHO Collaborative Study of neoplasia and steroid contraceptives. Combined oral contraceptives and gallbladder cancer. Int J Epidemiol. 1989;18(2):309–14.

    Article  Google Scholar 

  51. Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, Xu F, et al. Risk factors for intrahepatic cholangiocarcinoma: a case–control study in China. World J Gastroenterol. 2008;14(4):632–5.

    Article  PubMed  Google Scholar 

  52. Grainge MJ, West J, Solaymani-Dodaran M, Aithal GP, Card TR. The antecedents of biliary cancer: a primary care case–control study in the United Kingdom. Br J Cancer. 2009;100(1):178–80.

    Article  PubMed  CAS  Google Scholar 

  53. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case–control study. Clin Gastroenterol Hepatol. 2007;5(10):1221–8.

    Article  PubMed  Google Scholar 

  54. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case–control study. Am J Gastroenterol. 2007;102(5):1016–21.

    Article  PubMed  Google Scholar 

  55. Mitacek EJ, Brunnemann KD, Hoffmann D, Limsila T, Suttajit M, Martin N, et al. Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand. Carcinogenesis. 1999;20(1):133–7.

    Article  PubMed  CAS  Google Scholar 

  56. Hardell L, Bengtsson NO, Jonsson U, Eriksson S, Larsson LG. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria—an epidemiological investigation. Br J Cancer. 1984;50(3):389–97.

    Article  PubMed  CAS  Google Scholar 

  57. Sawanyawisuth K. Genes and cholangiocarcinoma. Southeast Asian J Trop Med Public Health. 2009;40(4):701–12.

    PubMed  CAS  Google Scholar 

  58. Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg. 2009;144(5):441–7. discussion 447.

    Article  PubMed  Google Scholar 

  59. Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at memorial Sloan-Kettering cancer centre (MSKCC). J Surg Oncol. 2008;98(7):485–9.

    Article  PubMed  CAS  Google Scholar 

  60. Scott TE, Carroll M, Cogliano FD, Smith BF, Lamorte WW. A case–control assessment of risk factors for gallbladder carcinoma. Dig Dis Sci. 1999;44(8):1619–25.

    Article  PubMed  CAS  Google Scholar 

  61. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates. Cancer. 1992;70(6):1498–501.

    Article  PubMed  CAS  Google Scholar 

  62. Strom BL, Soloway RD, Rios-Dalenz JL, Rodriguez-Martinez HA, West SL, Kinman JL, et al. Risk factors for gallbladder cancer. An international collaborative case–control study. Cancer. 1995;76(10):1747–56.

    Article  PubMed  CAS  Google Scholar 

  63. Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4(9):695–706.

    Article  PubMed  CAS  Google Scholar 

  64. Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology. 1998;115(4):937–46.

    Article  PubMed  CAS  Google Scholar 

  65. Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg. 2002;89(8):962–70.

    Article  PubMed  CAS  Google Scholar 

  66. Watanapa P. Cholangiocarcinoma in patients with opisthorchiasis. Br J Surg. 1996;83(8):1062–4.

    Article  PubMed  CAS  Google Scholar 

  67. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case–control study in Pusan, Korea. Int J Epidemiol. 1996;25(5):933–40.

    Article  PubMed  CAS  Google Scholar 

  68. Kim YI. Liver carcinoma and liver fluke infection. Arzneimittelforschung. 1984;34(9B):1121–6.

    PubMed  CAS  Google Scholar 

  69. Kurathong S, Lerdverasirikul P, Wongpaitoon V, Pramoolsinsap C, Kanjanapitak A, Varavithya W, et al. Opisthorchis viverrini infection and cholangiocarcinoma. A prospective, case–controlled study. Gastroenterology. 1985;89(1):151–6.

    PubMed  CAS  Google Scholar 

  70. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health. 2004;9(5):588–94.

    Article  PubMed  CAS  Google Scholar 

  71. Lim MK, Ju YH, Franceschi S, Oh JK, Kong HJ, Hwang SS, et al. Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg. 2006;75(1):93–6.

    PubMed  Google Scholar 

  72. Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis. 2005;5(1):31–41.

    Article  PubMed  Google Scholar 

  73. Parkin DM, Srivatanakul P, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, et al. Liver cancer in Thailand. I. A case–control study of cholangiocarcinoma. Int J Cancer. 1991;48(3):323–8.

    Article  PubMed  CAS  Google Scholar 

  74. Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, et al. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer. 1994;59(4):505–9.

    Article  PubMed  CAS  Google Scholar 

  75. Honjo S, Srivatanakul P, Sriplung H, Kikukawa H, Hanai S, Uchida K, et al. Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer. 2005;117(5):854–60.

    Article  PubMed  CAS  Google Scholar 

  76. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, et al. Cholangiocarcinoma and Clonorchis sinensis infection: a case–control study in Korea. J Hepatol. 2006;44(6):1066–73.

    Article  PubMed  Google Scholar 

  77. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case–control study. Am J Gastroenterol. 2008;103(7):1716–20.

    Article  PubMed  Google Scholar 

  78. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci. 2010 Mar;101(3):579–85.

    Article  PubMed  CAS  Google Scholar 

  79. Nagaoka T, Ohkawa S, Ito Y, Tamai S, Tarao K, Sugimasa Y, et al. A case of minute cholangiocellular carcinoma which was found in the follow-up periods of liver cirrhosis and was indistinguishable from hepatocellular carcinoma on hepatic angiography. Nippon Shokakibyo Gakkai Zasshi. 1991;88(6):1369–74.

    PubMed  CAS  Google Scholar 

  80. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer. 2000;88(11):2471–7.

    Article  PubMed  CAS  Google Scholar 

  81. Lu H, Ye MQ, Thung SN, Dash S, Gerber MA. Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients. Chin Med J. 2000;113(12):1138–41.

    PubMed  CAS  Google Scholar 

  82. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer. 2008;122(8):1849–53.

    Article  PubMed  CAS  Google Scholar 

  83. Liu XF, Zou SQ, Qiu FZ. Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus. Hepatobiliary Pancreat Dis Int. 2003;2(2):285–9.

    PubMed  Google Scholar 

  84. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol. 2002;17(10):1049–55.

    Article  PubMed  Google Scholar 

  85. Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci. 2004;95(7):592–5.

    Article  PubMed  CAS  Google Scholar 

  86. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology. 2009;49(1):116–23.

    Article  PubMed  Google Scholar 

  87. Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer. 2009;100(11):1765–70.

    Article  PubMed  CAS  Google Scholar 

  88. Nath G, Singh H, Shukla VK. Chronic typhoid carriage and carcinoma of the gallbladder. Eur J Cancer Prev. 1997;6(6):557–9.

    Article  PubMed  CAS  Google Scholar 

  89. Shukla VK, Singh H, Pandey M, Upadhyay SK, Nath G. Carcinoma of the gallbladder—is it a sequel of typhoid? Dig Dis Sci. 2000;45(5):900–3.

    Article  PubMed  CAS  Google Scholar 

  90. Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol. 2000;95(3):784–7.

    Article  PubMed  CAS  Google Scholar 

  91. Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res. 2002;93(7):842–7.

    Article  PubMed  CAS  Google Scholar 

  92. Metz DC. Helicobacter colonization of the biliary tree: commensal, pathogen, or spurious finding? Am J Gastroenterol. 1998;93(10):1996–8.

    PubMed  CAS  Google Scholar 

  93. Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis. 2002;23(11):1927–31.

    Article  PubMed  CAS  Google Scholar 

  94. Kobayashi T, Harada K, Miwa K, Nakanuma Y. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci. 2005;50(5):862–7.

    Article  PubMed  CAS  Google Scholar 

  95. Murata H, Tsuji S, Tsujii M, Fu HY, Tanimura H, Tsujimoto M, et al. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther. 2004;20 Suppl 1:90–4.

    Article  PubMed  Google Scholar 

  96. Roa I, Ibacache G, Carvallo J, Melo A, Araya J, De Aretxabala X, et al. Microbiological study of gallbladder bile in a high risk zone for gallbladder cancer. Rev Med Chil. 1999;127(9):1049–55.

    PubMed  CAS  Google Scholar 

  97. Lee SS, Kim MH, Lee SK, Jang SJ, Song MH, Kim KP, et al. Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer. 2004;100(4):783–93.

    Article  PubMed  Google Scholar 

  98. Taguchi J, Yasunaga M, Kojiro M, Arita T, Nakayama T, Simokobe T. Intrahepatic and extrahepatic biliary papillomatosis. Arch Pathol Lab Med. 1993;117(9):944–7.

    PubMed  CAS  Google Scholar 

  99. Wistuba II, Miquel JF, Gazdar AF, Albores-Saavedra J. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol. 1999;30(1):21–5.

    Article  PubMed  CAS  Google Scholar 

  100. Okamoto M, Okamoto H, Kitahara F, Kobayashi K, Karikome K, Miura K, et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am J Gastroenterol. 1999;94(2):446–50.

    Article  PubMed  CAS  Google Scholar 

  101. Voyles CR, Smadja C, Shands WC, Blumgart LH. Carcinoma in choledochal cysts. Age-related incidence. Arch Surg. 1983;118(8):986–8.

    Article  PubMed  CAS  Google Scholar 

  102. Song HK, Kim MH, Myung SJ, Lee SK, Kim HJ, Yoo KS, et al. Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone. Korean J Intern Med. 1999;14(2):1–8.

    PubMed  CAS  Google Scholar 

  103. Lipsett PA, Pitt HA, Colombani PM, Boitnott JK, Cameron JL. Choledochal cyst disease. A changing pattern of presentation. Ann Surg. 1994;220(5):644–52.

    Article  PubMed  CAS  Google Scholar 

  104. Scott J, Shousha S, Thomas HC, Sherlock S. Bile duct carcinoma: a late complication of congenital hepatic fibrosis. Case report and review of literature. Am J Gastroenterol. 1980;73(2):113–9.

    PubMed  CAS  Google Scholar 

  105. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366(9493):1303–14.

    Article  PubMed  Google Scholar 

  106. Pisano G, Donlon JB, Platell C, Hall JC. Cholangiocarcinoma in a type III choledochal cyst. Aust N Z J Surg. 1991;61(11):855–7.

    Article  PubMed  CAS  Google Scholar 

  107. Kale IT, Kuzu MA. Porta choledochal fistula: an unusual complication of a cholangiocarcinoma arising from a type I choledochal cyst. Eur J Surg Oncol. 1997;23(2):188–9.

    PubMed  CAS  Google Scholar 

  108. Bova JG, Dempsher CJ, Sepulveda G. Cholangiocarcinoma associated with a type 2 choledochal cyst. Gastrointest Radiol. 1983;8(1):41–3.

    Article  PubMed  CAS  Google Scholar 

  109. Robertson JF, Raine PA. Choledochal cyst: a 33-year review. Br J Surg. 1988;75(8):799–801.

    Article  PubMed  CAS  Google Scholar 

  110. de Vries JS, de Vries S, Aronson DC, Bosman DK, Rauws EA, Bosma A, et al. Choledochal cysts: age of presentation, symptoms, and late complications related to Todani’s classification. J Pediatr Surg. 2002;37(11):1568–73.

    Article  PubMed  Google Scholar 

  111. Ohtsuka T, Inoue K, Ohuchida J, Nabae T, Takahata S, Niiyama H, et al. Carcinoma arising in choledochocele. Endoscopy. 2001;33(7):614–9.

    Article  PubMed  CAS  Google Scholar 

  112. Hu B, Gong B, Zhou DY. Association of anomalous pancreaticobiliary ductal junction with gallbladder carcinoma in Chinese patients: an ERCP study. Gastrointest Endosc. 2003;57(4):541–5.

    Article  PubMed  Google Scholar 

  113. Chijiiwa K, Kimura H, Tanaka M. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst. Int Surg. 1995;80(1):61–4.

    PubMed  CAS  Google Scholar 

  114. Funabiki T, Matsubara T, Ochiai M, Marugami Y, Sakurai Y, Hasegawa S, et al. Surgical strategy for patients with pancreaticobiliary maljunction without choledocal dilatation. Keio J Med. 1997;46(4):169–72.

    Article  PubMed  CAS  Google Scholar 

  115. Elnemr A, Ohta T, Kayahara M, Kitagawa H, Yoshimoto K, Tani T, et al. Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer. Hepatogastroenterology. 2001;48(38):382–6.

    PubMed  CAS  Google Scholar 

  116. Sugiyama M, Atomi Y. Anomalous pancreaticobiliary junction without congenital choledochal cyst. Br J Surg. 1998;85(7):911–6.

    Article  PubMed  CAS  Google Scholar 

  117. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341(18):1368–78.

    Article  PubMed  Google Scholar 

  118. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009;50(1):158–64.

    Article  PubMed  Google Scholar 

  119. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002;36(3):321–7.

    Article  PubMed  Google Scholar 

  120. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99(3):523–6.

    Article  PubMed  Google Scholar 

  121. de Groen PC. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen? Hepatology. 2000;31(1):247–8.

    Article  PubMed  Google Scholar 

  122. Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case–control study. Hepatology. 1998;27(2):311–6.

    Article  PubMed  CAS  Google Scholar 

  123. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 1995;332(14):924–33.

    Article  PubMed  CAS  Google Scholar 

  124. Wiesner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc. 1994;69(10):969–82.

    PubMed  CAS  Google Scholar 

  125. Rosen CB, Nagorney DM, Wiesner RH, Coffey Jr RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991;213(1):21–5.

    Article  PubMed  CAS  Google Scholar 

  126. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38(4):610–5.

    Article  PubMed  CAS  Google Scholar 

  127. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case–control study. Hepatology. 2000;31(1):7–11.

    Article  PubMed  CAS  Google Scholar 

  128. Stauffer MH, Sauer WG, Dearing WH, Baggenstoss AH. The spectrum of cholestatic hepatic disease. JAMA. 1965;191:829–37.

    Article  PubMed  CAS  Google Scholar 

  129. Ham JM. Tumors of biliary epithelium and ulcerative colitis. Ann Surg. 1968;168(6):1088–93.

    Article  PubMed  CAS  Google Scholar 

  130. Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study. Scand J Gastroenterol. 1997;32(10):1042–5.

    Article  PubMed  CAS  Google Scholar 

  131. Yachimski P, Pratt DS. Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol. 2008;42(2):178–90.

    Article  PubMed  Google Scholar 

  132. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer. 2007;96(9):1457–61.

    PubMed  CAS  Google Scholar 

  133. Rai A, Mohapatra SC, Shukla HS. A review of association of dietary factors in gallbladder cancer. Indian J Cancer. 2004;41(4):147–51.

    PubMed  Google Scholar 

  134. Pandey M, Shukla VK. Diet and gallbladder cancer: a case–control study. Eur J Cancer Prev. 2002;11(4):365–8.

    Article  PubMed  CAS  Google Scholar 

  135. Serra I, Yamamoto M, Calvo A, Cavada G, Baez S, Endoh K, et al. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer. 2002;102(4):407–11.

    Article  PubMed  CAS  Google Scholar 

  136. Rai A, Mohapatra SC, Shukla HS. Correlates between vegetable consumption and gallbladder cancer. Eur J Cancer Prev. 2006;15(2):134–7.

    Article  PubMed  Google Scholar 

  137. Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000;95(6):1402–10.

    Article  PubMed  CAS  Google Scholar 

  138. Liang HP, Cheung WK, Su FH, Chu FY. Porcelain gallbladder. J Am Geriatr Soc. 2008;56(5):960–1.

    Article  PubMed  Google Scholar 

  139. Towfigh S, McFadden DW, Cortina GR, Thompson Jr JE, Tompkins RK, Chandler C, et al. Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surg. 2001;67(1):7–10.

    PubMed  CAS  Google Scholar 

  140. Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery. 2001;129(6):699–703.

    Article  PubMed  CAS  Google Scholar 

  141. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology. 1998;28(4):921–5.

    Article  PubMed  CAS  Google Scholar 

  142. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89(18):1360–5.

    Article  PubMed  CAS  Google Scholar 

  143. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 1996;88(20):1472–7.

    Article  PubMed  CAS  Google Scholar 

  144. Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 1995;55(12):2511–5.

    PubMed  CAS  Google Scholar 

  145. Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol. 1996;27(4):360–5.

    Article  PubMed  CAS  Google Scholar 

  146. Masuhara S, Kasuya K, Aoki T, Yoshimatsu A, Tsuchida A, Koyanagi Y. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 2000;7(2):198–205.

    Article  PubMed  CAS  Google Scholar 

  147. Hidaka E, Yanagisawa A, Seki M, Takano K, Setoguchi T, Kato Y. High frequency of K-ras mutations in biliary duct carcinomas of cases with a long common channel in the papilla of Vater. Cancer Res. 2000;60(3):522–4.

    PubMed  CAS  Google Scholar 

  148. Hanada K, Tsuchida A, Iwao T, Eguchi N, Sasaki T, Morinaka K, et al. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol. 1999;94(6):1638–42.

    Article  PubMed  CAS  Google Scholar 

  149. Isa T, Tomita S, Nakachi A, Miyazato H, Shimoji H, Kusano T, et al. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma. Hepatogastroenterology. 2002;49(45):604–8.

    PubMed  CAS  Google Scholar 

  150. Ohashi K, Nakajima Y, Kanehiro H, Tsutsumi M, Taki J, Aomatsu Y, et al. Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. Gastroenterology. 1995;109(5):1612–7.

    Article  PubMed  CAS  Google Scholar 

  151. Terada T, Nakanuma Y, Sirica AE. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis. Hum Pathol. 1998;29(2):175–80.

    Article  PubMed  CAS  Google Scholar 

  152. Aishima SI, Taguchi KI, Sugimachi K, Shimada M, Tsuneyoshi M. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. Histopathology. 2002;40(3):269–78.

    Article  PubMed  Google Scholar 

  153. Tannapfel A, Weinans L, Geissler F, Schutz A, Katalinic A, Kockerling F, et al. Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Dig Dis Sci. 2000;45(2):317–24.

    Article  PubMed  CAS  Google Scholar 

  154. Diamantis I, Karamitopoulou E, Perentes E, Zimmermann A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology. 1995;22(3):774–9.

    Article  PubMed  CAS  Google Scholar 

  155. Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. J Hepatobiliary Pancreat Surg. 2000;7(4):426–31.

    Article  PubMed  CAS  Google Scholar 

  156. Suto T, Sugai T, Nakamura S, Funato O, Nitta H, Sasaki R, et al. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct. Cancer. 1998;82(1):86–95.

    Article  PubMed  CAS  Google Scholar 

  157. Rizzi PM, Ryder SD, Portmann B, Ramage JK, Naoumov NV, Williams R. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis. Gut. 1996;38(2):265–8.

    Article  PubMed  CAS  Google Scholar 

  158. Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis. 2004;24(2):139–54.

    Article  PubMed  CAS  Google Scholar 

  159. Tannapfel A, Benicke M, Katalinic A, Uhlmann D, Kockerling F, Hauss J, et al. Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut. 2000;47(5):721–7.

    Article  PubMed  CAS  Google Scholar 

  160. Taniai M, Higuchi H, Burgart LJ, Gores GJ. p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. Gastroenterology. 2002;123(4):1090–8.

    Article  PubMed  CAS  Google Scholar 

  161. Momoi H, Okabe H, Kamikawa T, Satoh S, Ikai I, Yamamoto M, et al. Comprehensive allelotyping of human intrahepatic cholangiocarcinoma. Clin Cancer Res. 2001;7(9):2648–55.

    PubMed  CAS  Google Scholar 

Download references

Conflicts of Interest

None

Financial Disclosure

None.

Grant Support

None

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT, 06032, USA

    Tarun Rustagi

  2. Division of Hematology and Oncology, Saint Francis Hospital and Medical Center, Hartford, CT, USA

    Constantin A. Dasanu

Authors
  1. Tarun Rustagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Constantin A. Dasanu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tarun Rustagi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rustagi, T., Dasanu, C.A. Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates. J Gastrointest Canc 43, 137–147 (2012). https://doi.org/10.1007/s12029-011-9284-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-011-9284-y

Keywords

Search

Navigation